Si-Bone (SIBN) Invested Capital (2019 - 2022)

Si-Bone (SIBN) posted quarterly Invested Capital of $1.5 million for Q3 2022, down 83.3% quarter-over-quarter from $8.7 million in Q1 2020.

Si-Bone (SIBN) Invested Capital (2019 - 2022) Analysis & Trends

Si-Bone's Invested Capital history runs 3 years deep, the most recent figure standing at $1.5 million for Q3 2022.

In Q3 2022, Invested Capital changed N/A year-over-year to $1.5 million; the TTM figure through Jun 2023 stood at $1.5 million (changed N/A YoY), while the FY2019 annual figure was $4.4 million, changed N/A from the prior year.
Invested Capital for Q3 2022 stood at $1.5 million, down from $8.7 million in the prior quarter.
The five-year high for Invested Capital was $8.7 million in Q1 2020, with the low at $1.5 million in Q3 2022.
The 3-year median for Invested Capital is $4.4 million (2019), against an average of $4.8 million.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Invested Cap. (Qtr)
1	Abbott Laboratories	198.95 Bn	193.35 Bn	7.27 Bn	3.01 Bn
2	Stryker	128.10 Bn	124.63 Bn	4.50 Bn	750.00 Mn
3	Medtronic	118.91 Bn	109.69 Bn	6.41 Bn	1.79 Bn
4	Boston Scientific	73.43 Bn	72.89 Bn	3.85 Bn	1.71 Bn
5	Edwards Lifesciences	51.91 Bn	47.66 Bn	1.35 Bn	-
6	Dexcom	34.52 Bn	32.58 Bn	830.00 Mn	-
7	GE HealthCare Technologies	33.94 Bn	31.83 Bn	2.18 Bn	2.00 Mn
8	Koninklijke Philips	26.37 Bn	23.05 Bn	4.55 Bn	1.34 Bn
9	Steris	23.14 Bn	22.66 Bn	684.20 Mn	243.40 Mn
10	Si-Bone	856.85 Mn	710.91 Mn	44.55 Mn	-

Download Data